The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update
Author:
Affiliation:
1. Department of Biomedicine, Pharmacology; Aarhus University; Aarhus C Denmark
2. Clinic for Plastic, Aesthetic and Hand Surgery; Otto-von-Guericke-University Magdeburg; Magdeburg Germany
Publisher
Wiley
Subject
Pharmacology,Toxicology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12912/fullpdf
Reference65 articles.
1. Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure;Fisker;Basic Clin Pharmacol Toxicol,2015
2. 2013 ESH/ESC Guidelines for the management of arterial hypertension;Mancia;Eur Heart J,2013
3. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies;Lewington;Lancet,2002
4. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people;Rapsomaniki;Lancet,2014
5. World Health Statistics 2016 Monitoring Health for the Sustainable Development Goals Sdgs World Health Organization 2016
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Three Polymorphs and Two Hydrates of a Multidrug Crystal Involving Gefitinib and Rhein: Characterization, Stability, and Solubility Aspects;Crystal Growth & Design;2024-05-13
2. Effects of sacubitril/valsartan versus olmesartan on left atrial structure in hypertensive patients without HFrEF: a randomized controlled trial;Cardiology Plus;2024-04-30
3. Treatment with Sacubitril/Valsartan Effectively Manages Hypertension and Ameliorates Left Ventricular Hypertrophy in Hemodialysis Patients;Blood Purification;2024
4. Benefits of sacubitril/valsartan use in patients with chronic heart failure after cardiac valve surgery: a single-center retrospective study;Journal of Cardiothoracic Surgery;2023-04-11
5. Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension;The Journal of Clinical Hypertension;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3